NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Eagle8,
I believe that model will be a recurring theme in the future, that DCVax is the base layer drug (safe, efficacious) and combination trials with other drugs will be testing if the other drug adds value as an optimized total treatment in a specific area.

And I think we know the reason why. DCVax not only has an excellent safety, efficacy, and quality of life profile, it also activates our body's immune memory. This is unique and key in the industry.

That leads me to think oncologists will use DCVax as a prophylactic treatment in their patients with early stage, benign, and non-malignant cancers, as a preventive measure so the cancer does not advance and metastasize. And because BP drugs focus on late-stage cancers, this can be like an unexplored green open field for NWBO.
Chiugray